Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the BreathID to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients With Cirrhosis in Need of Liver Transplantation

NCT00375011 is registered in ClinicalTrials.gov with Meridian Bioscience, Inc. as lead sponsor.

NCT NCT00375011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00375011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the BreathID to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Patients With Cirrhosis in Need of Liver Transplantation
Lead sponsor
Meridian Bioscience, Inc.
Phase
Observational
Overall status
Terminated
Start date
September 30, 2008
Completion date
October 31, 2011
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis